Deutsche Bank Maintains Buy on SmartRent, Lowers Price Target to $5
Deutsche Bank analyst Sidney Ho maintains SmartRent (NYSE:SMRT) with a Buy and lowers the price target from $6 to $5.
Cantor Fitzgerald Maintains Overweight on SmartRent, Lowers Price Target to $4
Cantor Fitzgerald analyst Brett Knoblauch maintains SmartRent (NYSE:SMRT) with a Overweight and lowers the price target from $4.25 to $4.
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Earnings Preview For SmartRent, Inc. Class A Common Stock
SmartRent, Inc. Class A Common Stock (NYSE:SMRT) is set to give its latest quarterly earnings report on Wednesday,…
12 Information Technology Stocks Moving In Wednesday’s After-Market Session
Gainers Taoping (NASDAQ:TAOP) stock moved upwards by 7.6% to $0.67 during Wednesday’s after-market session. The market value of…
Morgan Stanley Maintains Equal-Weight on SmartRent, Raises Price Target to $2.9
Morgan Stanley analyst Erik Woodring maintains SmartRent (NYSE:SMRT) with a Equal-Weight and raises the price target from $2.8 to $2.9.
SmartRent Surpasses 500,000 Units Deployed
SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), a leading provider of smart home and smart building automation for residents, property owners, managers, developers and homebuilders, today
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
